{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:59Z","timestamp":1794047519908,"version":"4.8.0"},"reference-count":21,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Mutant calreticulin (CALR) activates the thrombopoietin (TPO) receptor MPL, thereby inducing the development of essential thrombocythemia and primary myelofibrosis. Mutant CALR, due to a frameshift mutation, loses the endoplasmic reticulum (ER) retention signal, the KDEL sequence and is released extracellularly. To examine the significance of the loss of the KDEL sequence in mutant CALR-induced MPL activation, a series of constructs were prepared, including mutant CALR plus KDEL (mutant CALRKDEL), mutant CALR plus the Venus tag and KDEL (mutant CALRVenus-KDEL), and wild-type (WT) CALR minus KDEL (CALR WT\u0394KDEL). UT-7\/TPO cells expressing mutant CALRKDEL exhibited autonomous cell growth in the absence of TPO, accompanied by the extracellular secretion of mutant CALRKDEL and subsequent activation of MPL. In contrast, UT-7\/TPO cells expressing mutant CALRVenus-KDEL did not exhibit autonomous cell growth or MPL activation without TPO as well as the reduced extracellular secretion of mutant CALRVenus-KDEL. These results suggest that the loss of KDEL function in mutant CALR is closely linked to MPL activation and the extracellular secretion of mutant CALR. While UT-7\/TPO cells expressing CALR WT\u0394KDEL did not exhibit autonomous cell growth, they were responsive to mutant CALR proteins added exogenously, as evidenced by STAT5 activity. Furthermore, CALR WT\u0394KDEL conferred mutant CALR sensitivity to MPL by recognizing the N-glycans of MPL while maintaining it in an immature form, which may bind to mutant CALR. In conclusion, deletion of the ER retention signal KDEL from CALR is a prerequisite for the expression of the immature form of MPL, which can interact with secreted mutant CALR.<\/jats:p>","DOI":"10.3324\/haematol.2025.287585","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:36:05Z","timestamp":1762418165000},"page":"1368-1379","source":"Crossref","is-referenced-by-count":2,"title":["Loss of KDEL function from a calreticulin frameshift mutation drives expression of an immature, mutant calreticulin-dependent form of the thrombopoietin receptor MPL"],"prefix":"10.3324","volume":"111","author":[{"given":"Nami","family":"Masubuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soji","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Edahiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"88009","doi-asserted-by":"crossref","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013; 369(25):2379-2390.","DOI":"10.1056\/NEJMoa1311347"},{"key":"88010","doi-asserted-by":"crossref","unstructured":"Nangalia J, Massie CE, Baxter EJ. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med. 2013; 369(25):2391-2405.","DOI":"10.1056\/NEJMoa1312542"},{"key":"88011","doi-asserted-by":"crossref","unstructured":"Araki M, Yang Y, Masubuchi N. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood. 2016; 127(10):1307-1316.","DOI":"10.1182\/blood-2015-09-671172"},{"key":"88012","doi-asserted-by":"crossref","unstructured":"Elf S, Abdelfattah NS, Chen E. Mutant calreticulin requires both its mutant C-terminus and the thrombopoietin receptor for oncogenic transformation. Cancer Discov. 2016; 6(4):368-381.","DOI":"10.1158\/2159-8290.CD-15-1434"},{"key":"88013","doi-asserted-by":"crossref","unstructured":"Chachoua I, Pecquet C, El-Khoury M. Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. Blood. 2016; 127(10):1325-1335.","DOI":"10.1182\/blood-2015-11-681932"},{"key":"88014","doi-asserted-by":"crossref","unstructured":"Araki M, Yang Y, Imai M. Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation. Leukemia. 2019; 33(1):122-131.","DOI":"10.1038\/s41375-018-0181-2"},{"key":"88015","doi-asserted-by":"crossref","unstructured":"Sonnichsen B, Fullekrug J, Nguyen Van P, Diekmann W, Robinson DG, Mieskes G. Retention and retrieval: both mechanisms cooperate to maintain calreticulin in the endoplasmic reticulum. J Cell Sci. 1994; 107(Pt 10):2705-2717.","DOI":"10.1242\/jcs.107.10.2705"},{"key":"88016","doi-asserted-by":"crossref","unstructured":"Liu P, Zhao L, Loos F. Immunosuppression by mutated calreticulin released from malignant cells. Mol Cell. 2020; 77(4):748-760.","DOI":"10.1016\/j.molcel.2019.11.004"},{"key":"88017","doi-asserted-by":"crossref","unstructured":"Pecquet C, Papadopoulos N, Balligand T. Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms. Blood. 2023; 141(8):917-929.","DOI":"10.1182\/blood.2022016846"},{"key":"88018","doi-asserted-by":"crossref","unstructured":"Masubuchi N, Araki M, Yang Y. Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface. Leukemia. 2020; 34(2):499-509.","DOI":"10.1038\/s41375-019-0564-z"},{"key":"88019","doi-asserted-by":"crossref","unstructured":"Pecquet C, Chachoua I, Roy A. Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants. Blood. 2019; 133(25):2669-2681.","DOI":"10.1182\/blood-2018-09-874578"},{"key":"88020","doi-asserted-by":"crossref","unstructured":"Sunami Y, Araki M, Hironaka Y. Inhibition of the NAD-dependent protein deacetylase SIRT2 induces granulocytic differentiation in human leukemia cells. PLoS One. 2013; 8(2):e57633.","DOI":"10.1371\/journal.pone.0057633"},{"key":"88021","doi-asserted-by":"crossref","unstructured":"Komatsu N, Kunitama M, Yamada M. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7\/TPO. Blood. 1996; 87(11):4552-4560.","DOI":"10.1182\/blood.V87.11.4552.bloodjournal87114552"},{"key":"88022","doi-asserted-by":"crossref","unstructured":"Albu RI, Constantinescu SN. Extracellular domain N-glycosylation controls human thrombopoietin receptor cell surface levels. Front Endocrinol (Lausanne). 2011; 2:71.","DOI":"10.3389\/fendo.2011.00071"},{"key":"88023","doi-asserted-by":"crossref","unstructured":"Saito Y, Ihara Y, Leach MR, Cohen-Doyle MF, Williams DB. Calreticulin functions in vitro as a molecular chaperone for both glycosylated and non-glycosylated proteins. EMBO J. 1999; 18(23):6718-6729.","DOI":"10.1093\/emboj\/18.23.6718"},{"key":"88024","doi-asserted-by":"crossref","unstructured":"Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: one protein, one gene, many functions. Biochem J. 1999; 344(Pt 2):281-292.","DOI":"10.1042\/bj3440281"},{"key":"88025","doi-asserted-by":"crossref","unstructured":"Parodi AJ. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem J. 2000; 348(Pt 1):1-13.","DOI":"10.1042\/bj3480001"},{"key":"88026","doi-asserted-by":"crossref","unstructured":"Hirano M, Adachi Y, Ito Y, Totani K. Calreticulin discriminates the proximal region at the N-glycosylation site of Glc1Man9GlcNAc2 ligand. Biochem Biophys Res Commun. 2015; 466(3):350-355.","DOI":"10.1016\/j.bbrc.2015.09.026"},{"key":"88027","doi-asserted-by":"crossref","unstructured":"Patil AR, Thomas CJ, Surolia A. Kinetics and the mechanism of interaction of the endoplasmic reticulum chaperone, calreticulin, with monoglucosylated (Glc1Man9GlcNAc2) substrate. J Biol Chem. 2000; 275(32):24348-24356.","DOI":"10.1074\/jbc.M003102200"},{"key":"88028","doi-asserted-by":"crossref","unstructured":"Cleyrat C, Darehshouri A, Steinkamp MP. Mpl traffics to the cell surface through conventional and unconventional routes. Traffic. 2014; 15(9):961-982.","DOI":"10.1111\/tra.12185"},{"key":"88029","doi-asserted-by":"crossref","unstructured":"Gerondopoulos A, Brauer P, Sobajima T. A signal capture and proofreading mechanism for the KDEL-receptor explains selectivity and dynamic range in ER retrieval. Elife. 2021; 10:e68380.","DOI":"10.7554\/eLife.68380"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/12978\/79038","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12978\/79871","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12978\/79038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:10:14Z","timestamp":1794046214000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/12978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2025.287585","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}